These variants, localized to the negative regulatory domain of MEK1, cause constitutive MAPK/ERK pathway activation, increased osteoblast proliferation, and impaired mineralization, thereby explaining the exuberant periosteal new bone formation characteristic of classical melorheostosis. Here, MAP2K1 is linked to melorheostosis.